PERSEUS Primary Analysis
PERSEUS: Primary Analysis of Phase III Trial With VRd ± Daratumumab in Patients With Newly Diagnosed Multiple Myeloma Eligible for ASCT

Released: December 14, 2023

Activity

Progress
1
Course Completed